2 news items
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
MAIA
6 Jun 24
.
"We remain steadfast in our goals for responsible access to capital. We have increased our access to cash while keeping dilution
MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market
MAIA
22 May 24
of revolutionizing oncology, leveraging advanced scientific research and technological advancements to drive its progress, with the goal of bringing
- Prev
- 1
- Next